These therapies, Rybelsus and Wegovy, represent a major shift in approaches to treating type 2 diabetes and, increasingly, excess weight. They function as GLP-1 GLP-1 analogs , mimicking the action of a https://bookmark-template.com/story29290275/copyright-semaglutide-understanding-the-glp-1-revolution